BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+32.57%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.65B
AUM Growth
+$9.65B
(+23%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
77.89%
Holding
100
New
5
Increased
16
Reduced
3
Closed
6
Top Buys
| 1 |
Insmed
INSM
|
$61.3M |
| 2 |
CRISPR Therapeutics
CRSP
|
$34.9M |
| 3 |
Summit Therapeutics
SMMT
|
$26.3M |
| 4 |
Immunovant
IMVT
|
$21.7M |
| 5 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$21.2M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arvinas
ARVN
$580M
| $9.99M | 0.1% |
+405,576
| New | +$9.99M |
|
52
Sana Biotechnology
SANA
$759M
| $9.9M | 0.1% |
2,380,949
| – | – |
|
53
Design Therapeutics
DSGN
$339M
| $9.38M | 0.1% |
1,743,725
+48,431
| +3% | +$261K |
|
54
Ionis Pharmaceuticals
IONS
$9.64B
| $8.95M | 0.09% |
+223,470
| New | +$8.95M |
|
|
OPT
55
DELISTED
Opthea Limited American Depositary Shares
OPT
| $8.85M | 0.09% |
2,173,622
| – | – |
|
56
Celldex Therapeutics
CLDX
$1.57B
| $8.42M | 0.09% |
247,644
| – | – |
|
57
Relay Therapeutics
RLAY
$709M
| $8.21M | 0.09% |
1,160,117
| – | – |
|
|
VERV
58
DELISTED
Verve Therapeutics
VERV
| $8.19M | 0.08% |
1,691,530
| – | – |
|
59
Taysha Gene Therapies
TSHA
$791M
| $8.05M | 0.08% |
4,004,756
| – | – |
|
60
Mirum Pharmaceuticals
MIRM
$3.75B
| $7.43M | 0.08% |
190,476
| – | – |
|
|
CTNM
61
Contineum Therapeutics
CTNM
$297M
| $5.98M | 0.06% |
312,500
| – | – |
|
62
Tango Therapeutics
TNGX
$745M
| $5.78M | 0.06% |
750,000
| – | – |
|
63
Skye Bioscience
SKYE
$104M
| $5.61M | 0.06% |
1,434,634
+934,634
| +187% | +$3.65M |
|
64
Vaxcyte
PCVX
$4.17B
| $5.59M | 0.06% |
48,885
| – | – |
|
65
Crinetics Pharmaceuticals
CRNX
$3.26B
| $5.31M | 0.06% |
103,927
| – | – |
|
|
DBVT
66
DBV Technologies
DBVT
$249M
| $5.11M | 0.05% |
7,307,131
| – | – |
|
67
KALA BIO
KALA
$105M
| $5.08M | 0.05% |
891,335
| – | – |
|
68
Generation Bio
GBIO
$40.3M
| $4.8M | 0.05% |
1,944,945
+737,988
| +61% | +$1.82M |
|
69
Alector
ALEC
$282M
| $4.32M | 0.04% |
927,264
| – | – |
|
70
Prime Medicine
PRME
$595M
| $3.98M | 0.04% |
1,028,466
| – | – |
|
71
Sagimet Biosciences
SGMT
$239M
| $3.83M | 0.04% |
1,381,898
| – | – |
|
72
Structure Therapeutics
GPCR
$1.14B
| $3.75M | 0.04% |
+85,500
| New | +$3.75M |
|
73
Arcturus Therapeutics
ARCT
$467M
| $3.51M | 0.04% |
151,329
| – | – |
|
|
HOOK
74
DELISTED
HOOKIPA Pharma
HOOK
| $3.5M | 0.04% |
812,814
-7,315,337
| -90% | -$4 |
|
75
Leap Therapeutics
LPTX
$12M
| $3.01M | 0.03% |
1,172,175
| – | – |
|